April 9, 2019
ImmunogenX Receives Major Grant from the National Institutes of Health (NIH) to Conduct a Clinical Trial for Latiglutenase
The study will further advance an unmet therapeutic need for celiac disease NEWPORT BEACH, Calif.–(BUSINESS WIRE)–The NIH’s National Institute of…